Myopia Management

John Rose has been successfully treating Myopia for almost 20 years with different types of contact lenses

Myopia (short-sightedness) is recognized by the World Health Organization as a rapidly increasing eye disease of pandemic proportions. Recent research shows that if both parents are short-sighted the likelihood of their children developing Myopia is around 1in 2 or 50%, if one parent is myopic its around 1 in 3. In the UK over the last 50 years the proportion of myopic children has doubled.

The reason you as a parent should be concerned about your children having or developing myopia, is that it puts them at a much greater risk of developing serious eye health issues when they are adults. Acting early and managing myopia progression dramatically reduces the risk of eye diseases and the possibility of blindness that is associated with high myopia.

Careful research has found that every 1 diopter reduction in myopia reduces risks of myopic maculopathy by 40%.
It is never too early to start Myopia Management.

If left untreated, Myopia normally stabilizes at about 21 years of age, however anecdotally we do see continued progression even in adults especially those who work in offices or who are spending a lot of time on electronic devices, and once it has developed Myopia is not reversible.

The best method to identify and manage Myopia is to have regular annual comprehensive eye health examinations as soon as your child starts going to school and certainly by age five or six. Then, undertake ongoing Myopia monitoring and treatment as recommended by the Optometrist.

John Rose has been successfully treating Myopia for almost 20 years with different types of contact lenses. As an official ZEISS lens partner we offer the innovative non-invasive Zeiss Myocare spectacle lens treatment for myopia control.

ZEISS MyoCare lenses. A better outlook on life at John Rose Eye Care.

Our first age-related myopia management portfolio with lens designs aimed to slow down the progression of myopia. MyoCare is backed by ZEISS innovation and more than a decade of experience in developing lenses to manage myopia progression.

  • Effective myopia management in children

  • Good vision for all viewing angles

  • Comfortable vision

  • Full UV protection

myopia image
IMG_3661

Looking for help with Myopia Control?

speak to us on 020 8546 9292

HOW TO SLOW DOWN THE PROGRESSION OF MYOPIA

The most effective methods of Myopia Management are as follows:

1. Myopia progression can be slowed down by wearing daily soft contact lenses. Contact lenses for Myopia Control are proven to reduce the rate of myopia progression in children by on average up to 59%.

2. New age-related myopia management lens solutions at John Rose Eye Care   

When not wearing contact lenses or if your children are not suitable for contact lenses, spectacles with ZEISS MYOCARE lenses are proven to slow down myopia progression. The ZEISS MyoCare designs show an average emmetropic progression ratio for axial length of up to 86% for children aged 10-12 years and up to 63% for children aged 7-9 years

ZEISS MyoCare and ZEISS MyoCare S

Different interventions have different effects. The same goes for the two different designs in the MyoCare portfolio. According to research results, there is a significant group difference in axial length and spherical equivalent refraction change between the untreated group wearing single vision correction and the treatment group wearing ZEISS MyoCare lenses. Based on this it is recommended to have separate designs for separate age groups:

  • MyoCare® for children younger than 10 years

  • MyoCare® S for children 10 years and older

John Rose, our practice optometrist will give you customised advice and instructions about wearing time during the myopia management consultation.

100% of children wearing ZEISS MyoCare designs adapted to the lenses within 1 day.

3. Ortho–K or overnight lenses. These are rigid contact lenses that act in a similar way to dental retainers and reshape the cornea. This has the effect of slowing down progression and also allowing clear vision during the day without wearing lenses. The disadvantage is a theoretical increased risk of developing eye infections and once the myopia has progressed beyond around -4.50 Dioptres it is ineffective.

4. Low dose Atropine (0.01%) has been shown to be effective, and is most commonly used as a dual therapy combining it with contact lenses / spectacles. However, currently it is not licensed for use in the UK (still undergoing clinical trials, results expected in around 2024) and is only available “off-label”.

5. Have Comprehensive 4D Eye Health check-ups regularly.

6. Spend more time outdoors (especially in early childhood) and drink enough water.

7. Take breaks from screen time. Follow the 30-30-30 rule – every 30 minutes look away into the distance, for instance outside, through a window at something that is more than 30 feet away from you for and do 30 full complete blinks for 30 seconds.

8. Be mindful of ergonomics when working at your desk – proper lighting, comfortable and healthy posture and distance to screen. Try to encourage your children to spend less time on electronic devices and more time outdoors.

ZEISS_MyoCare_Email_Banner

The protocol for Myopia Management at John Rose Eye Care

Myopia Management is an ongoing treatment and clients MUST enroll on our in house Direct Debit scheme for ongoing monitoring and management. This is a medical treatment and its success depends on regular eye examinations, measurements and monitoring and is not currently provided by the NHS.
We have been a fully private practice for many years, allowing us to spend more time with our clients and invest in the latest technology to provide all of our clients with the benefits of up to date technology and treatments.
Our fee structure reflects the time and expertise required to monitor and treat your children’s myopia in the most effective manner.

img4

References:
Bullimore, M. (2019). Myopia control: why each dioptre matters. Contact Lens and Anterior Eye, 42(6), e23.
Bullimore, M. A., & Richdale, K. (2020). Myopia Control 2020: Where are we and where are we heading?. Ophthalmic and Physiological Optics, 40(3), 254-270.

Looking for help with Myopia Control?

speak to us on 020 8546 9292